WallStSmart

Imax Corp (IMAX)vsMeta Platforms Inc. (META)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Meta Platforms Inc. generates 54756% more annual revenue ($228.25B vs $416.08M). META leads profitability with a 29.8% profit margin vs 9.8%. META appears more attractively valued with a PEG of 0.83. META earns a higher WallStSmart Score of 71/100 (B).

IMAX

Buy

63

out of 100

Grade: C+

Growth: 8.0Profit: 6.5Value: 4.0Quality: 6.0
Piotroski: 4/9Altman Z: 1.08

META

Strong Buy

71

out of 100

Grade: B

Growth: 6.0Profit: 9.5Value: 8.0Quality: 7.0
Piotroski: 3/9Altman Z: 2.88
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

IMAXSignificantly Overvalued (-30.6%)

Margin of Safety

-30.6%

Fair Value

$27.95

Current Price

$48.49

$20.54 premium

UndervaluedFair: $27.95Overvalued
METAUndervalued (+38.0%)

Margin of Safety

+38.0%

Fair Value

$949.28

Current Price

$592.10

$357.18 discount

UndervaluedFair: $949.28Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

IMAX3 strengths · Avg: 8.0/10
PEG RatioValuation
0.898/10

Growing faster than its price suggests

Operating MarginProfitability
22.5%8/10

Strong operational efficiency at 22.5%

EPS GrowthGrowth
35.0%8/10

Earnings expanding 35.0% YoY

META6 strengths · Avg: 9.0/10
Market CapQuality
$1.50T10/10

Mega-cap, among the largest globally

Operating MarginProfitability
30.9%10/10

Strong operational efficiency at 30.9%

Return on EquityProfitability
26.1%9/10

Every $100 of equity generates 26 in profit

Profit MarginProfitability
29.8%9/10

Keeps 30 of every $100 in revenue as profit

PEG RatioValuation
0.838/10

Growing faster than its price suggests

Revenue GrowthGrowth
28.0%8/10

Revenue surging 28.0% year-over-year

Areas to Watch

IMAX2 concerns · Avg: 2.0/10
P/E RatioValuation
65.5x2/10

Premium valuation, high expectations priced in

Altman Z-ScoreHealth
1.082/10

Distress zone — elevated risk

META2 concerns · Avg: 2.5/10
Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

EPS GrowthGrowth
-13.4%2/10

Earnings declined 13.4%

Comparative Analysis Report

WallStSmart Research

Bull Case : IMAX

The strongest argument for IMAX centers on PEG Ratio, Operating Margin, EPS Growth. Revenue growth of 12.2% demonstrates continued momentum. PEG of 0.89 suggests the stock is reasonably priced for its growth.

Bull Case : META

The strongest argument for META centers on Market Cap, Operating Margin, Return on Equity. Profitability is solid with margins at 29.8% and operating margin at 30.9%. Revenue growth of 28.0% demonstrates continued momentum.

Bear Case : IMAX

The primary concerns for IMAX are P/E Ratio, Altman Z-Score. A P/E of 65.5x leaves little room for execution misses.

Bear Case : META

The primary concerns for META are Piotroski F-Score, EPS Growth.

Key Dynamics to Monitor

IMAX profiles as a value stock while META is a growth play — different risk/reward profiles.

META carries more volatility with a beta of 1.24 — expect wider price swings.

META is growing revenue faster at 28.0% — sustainability is the question.

META generates stronger free cash flow (1.7B), providing more financial flexibility.

Bottom Line

META scores higher overall (71/100 vs 63/100), backed by strong 29.8% margins and 28.0% revenue growth. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Imax Corp

COMMUNICATION SERVICES · ENTERTAINMENT · USA

IMAX Corporation, is a worldwide entertainment technology company. The company is headquartered in Mississauga, Canada.

Visit Website →

Meta Platforms Inc.

COMMUNICATION SERVICES · INTERNET CONTENT & INFORMATION · USA

Meta Platforms, Inc. develops products that enable people to connect and share with friends and family through mobile devices, PCs, virtual reality headsets, wearables and home devices around the world. The company is headquartered in Menlo Park, California.

Visit Website →

Want to dig deeper into these stocks?